Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A concise guide to selecting between hardware and software wallets, outlining scenarios where each type excels and where to be cautious.
19,747 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
Want to understand how Extra Space Storage (EXR) earns and how to read its earnings calls like a pro? This deep dive ...
A Sunrun director recently disposed of a large block of shares. This article breaks down insider sales, what they imp...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
Netflix stock climbed today as investors weighed growth momentum and the potential move of a major deal. This article...
As investors prepare for Personalis (PSNL) 2025 earnings, this guide breaks down what to watch, how to interpret the ...
In 2025, Interactive Brokers stayed focused on the engine that powers long-term success: scale, discipline, and momen...
After a rocky stretch, Celsius Holdings staged a notable revival. This guide breaks down the miss celsius stock comeb...
As energy markets tilt between supply concerns and resilient cash flow, March can be a strategic moment to position f...
Markets in March 2026 are volatile, pushing traders to seek reliable borrow access and fast execution. This article i...